SCHEMBL17850520

SCHEMBL17850520

CN1CCN(CCS(=O)(=O)Cl)CC1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PAOX Q6QHF9 1/20 0.38
MC4R P32245 1/20 0.36
LMNA P02545 1/20 0.34
SIGMAR1 Q99720 3/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
TMEM97 Q5BJF2 1/20 0.34
RECQL P46063 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA9 Q16790 1/20 0.33
TP53 P04637 1/20 0.33
HTR7 P34969 1/20 0.33
CHKA P35790 1/20 0.32
ATM Q13315 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
CNR1 P21554 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6622067 0.85 PAOX (0.43) PAOXSIGMAR1L3MBTL1TP53HTR7
SCHEMBL29993988 0.81 HRH3 (0.40) SIGMAR1CYP1A2L3MBTL1SMN1; SMN2
SCHEMBL13485582 0.79 PAOX (0.39) PAOXMC4RSIGMAR1RECQLCA1
SCHEMBL12015831 0.79 PAOX (0.39) PAOXMC4RLMNASIGMAR1RECQL
SCHEMBL17102198 0.77 CA2 (0.40) PAOXMC4RLMNASIGMAR1CA1
SCHEMBL18803169 0.77 PAOX (0.38) PAOXMC4RSIGMAR1RECQLCA1
SCHEMBL3607141 0.77 PAOX (0.42) PAOXLMNACYP1A2L3MBTL1CA1
SCHEMBL731431 0.76 KMT2A (0.51) LMNACA1CA2CA9SMN1; SMN2
Hydrochloric Acid SCHEMBL23753187 0.74 KMT2A (0.50) LMNACA1CA2CA9SMN1; SMN2
SCHEMBL13588746 0.74 PAOX (0.36) PAOXSIGMAR1L3MBTL1CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2643299-B1 BIPYRIDINE SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES OR CONDITIONS NOSCIRA SA (ES) 2016-06-22 EP disclosed